
PurMinds Enterprises Targets OTC Uplisting Following Financial Cleanup
Las Vegas-based neuroscience firm PurMinds Enterprises has submitted its fiscal 2026 second-quarter financials to OTC Markets, signaling a pivot toward institutional-grade transparency. The company is currently undergoing a PCAOB audit, a prerequisite for its planned application to uplist to the OTCQB or OTCQX market tiers later this year.


























